Alexium International Group Limited
AXIIF
Other OTC0.00
USD
- -
- -
ISIN
AU000000AJX6
Return %
Stock
S&P500
1Y
150.00
26.57
3Y
150.00
76.60
5Y
-97.33
78.48
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- CEO
- William Timothy Blackburn Jr.
- Full Time Employees
- 29
- Sector
- Basic Materials
- Industry
- Chemicals - Specialty
- Address
- 350 West Phillips Road Greer SC United States of America 29650
- IPO Date
- Aug 24, 2018
- Website
- alexiuminternational.com
- Similar Companies
- Business
- Alexium International Group Limited Alexium International Group Limited is an Australia-based performance chemicals provider for advanced materials applications, with a focus on flame retardancy and thermal management technologies. The company develops and commercializes proprietary solutions including thermal regulation products such as AlexiCool, a phase-change material (PCM) finishing treatment for textiles and foams; BioCool, a biobased microencapsulated PCM line for bedding; Eclipsys, a perpetual cooling technology for textile and foam-based products; and DelCool, a thermal management product; alongside flame-retardant offerings like AlexiFlam for mattress applications, AlexiGuard, and AlexiShield. These high-performance, patent-protected chemistries serve key markets including bedding and mattresses, military uniforms and body armor, workwear, transportation seating, apparel, and outdoor textiles, with primary operations in the United States and Australia. Founded in 2009 through the acquisition of US Air Force Research Laboratory technology for reactive surface treatments, Alexium International Group Limited maintains its global headquarters in Greer, South Carolina, with additional facilities in Melbourne, Victoria, and a former base in Perth, Western Australia. The company targets manufacturers and brands in consumer goods, defense, and industrial sectors, offering customized integrations via slurry, cake, and dry powder PCM formats for coatings, foams, and fibers. Recent developments include the commercial launch of the Total Mattress Cooling System (TMCS), an integrated solution combining multiple AlexiCool products valued at over US$2 million annually in near-term potential; introduction of AlexiCool Phonon, a breakthrough perpetual cooling technology; expansion of BioCool sales; and custom projects such as DelCool-based luxury mattresses with major brands for late 2025 floor models and 2026 release, alongside high-tech pillows and Eclipsys mattress opportunities. In 2025, Alexium streamlined operations for bedding innovation, built its sales team for scaling, and continued investor engagements through quarterly updates, webinars, and its November 2025 Annual General Meeting, while navigating executive changes like the resignation of Chief Technology Officer Bob Brookins in August 2025.
Alexium International Group Limited (AXIIF) Discusses Microtek Acquisition, Business Progress and Capital Raising Transcript
Alexium International Group Limited (AXIIF) Discusses First Half Results, Microtek Acquisition, and Outlook for Business Recovery Prepared Remarks Transcript
Alexium International Group Limited (AXIIF) Discusses Acquisition of Microencapsulation and PCM Businesses of Microtek and Associated Entitlement Offer Transcript
Alexium International Group Limited (AXIIF) Shareholder/Analyst Call Prepared Remarks Transcript
Alexium International Group Limited (AXIIF) Q4 2025 Earnings Call Prepared Remarks Transcript